Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for KMC Speciality Hospitals (India)'s Debt-to-EBITDA or its related term are showing as below:
NSE:KMCSHIL'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.38 Med: 0.96 Max: 1.61
Current: 0.79
During the past 13 years, the highest Debt-to-EBITDA Ratio of KMC Speciality Hospitals (India) was 1.61. The lowest was 0.38. And the median was 0.96.
NSE:KMCSHIL's Debt-to-EBITDA is ranked better than 73.96% of 480
companies
in the Healthcare Providers & Services industry
Industry Median: 2.185
vs NSE:KMCSHIL: 0.79
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
KMC Speciality Hospitals (India) Debt-to-EBITDA Related Terms
KMC Speciality Hospitals (India) Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, KMC Speciality Hospitals (India)'s Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMC Speciality Hospitals (India) Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, KMC Speciality Hospitals (India)'s Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where KMC Speciality Hospitals (India)'s Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
KMC Speciality Hospitals (India) (NSE:KMCSHIL) has a Debt-to-EBITDA of 0.00 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on KMC Speciality Hospitals (India). Over the past decade, KMC Speciality Hospitals (India)'s Debt-to-EBITDA has ranged from 0.38 to 1.61. According to the industry distribution chart, KMC Speciality Hospitals (India) ranks #125 out of 480 companies in the Healthcare Providers & Services industry, placing it in the top 26%.
Is KMC Speciality Hospitals (India)'s Debt-to-EBITDA too high?
KMC Speciality Hospitals (India)'s current Debt-to-EBITDA is 0.00. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 1.61. Based on the distribution chart, KMC Speciality Hospitals (India) ranks #125 out of 480 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, KMC Speciality Hospitals (India) has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KMC Speciality Hospitals (India)'s Debt-to-EBITDA compare to ?
According to the Healthcare Providers & Services industry distribution chart, KMC Speciality Hospitals (India) ranks #125 out of 480 companies for Debt-to-EBITDA. This puts KMC Speciality Hospitals (India) in the upper half of its industry. The industry median Debt-to-EBITDA is 2.19. Historically, KMC Speciality Hospitals (India)'s own Debt-to-EBITDA has ranged from 0.38 to 1.61 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 480 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on KMC Speciality Hospitals (India). For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMC Speciality Hospitals (India)'s current Debt-to-EBITDA is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMC Speciality Hospitals (India) stock overvalued right now?
Based on GuruFocus' analysis, KMC Speciality Hospitals (India) (NSE:KMCSHIL) is currently considered Fairly Valued. The stock's GF Value™ is ₹130.07, compared to a current price of ₹141.65 — trading 8.9% above its estimated fair value. The current Debt-to-EBITDA is 0.00. KMC Speciality Hospitals (India)'s overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For KMC Speciality Hospitals (India) (NSE:KMCSHIL), the current Debt-to-EBITDA is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMC Speciality Hospitals (India) (NSE:KMCSHIL) Overvalued in 2026?
Based on GuruFocus' analysis, KMC Speciality Hospitals (India) stock appears to be overvalued.
The current stock price of ₹141.65 is trading 8.9% above its estimated GF Value™ of ₹130.07.
GuruFocus considers KMC Speciality Hospitals (India) to be Fairly Valued.
Key valuation signals for NSE:KMCSHIL:
Debt-to-EBITDA: 0.00
GF Value™: ₹130.07 vs. price of ₹141.65 (8.9% above fair value)
No single metric tells the full story. See the NSE:KMCSHIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMC Speciality Hospitals (India) Ltd is a healthcare services and pharmacy company. It is engaged in the business of rendering medical and healthcare services. The company offers varieties of departments and care centers such as cardiac science, neurology and neuroscience, orthopedics, spine surgery, gastroenterology, liver diseases, and transplantation and vascular surgery. The company's sole operating segment is Medical and Healthcare Services. The company operates solely in India.
73GF Score
Get the complete analysis for NSE:KMCSHIL
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KMCSHIL has been successfully added to your 
